Molecular diagnoses of century-old childhood tumours reveals cancer causing mutations

24 May 2017, 2:29 p.m.

Archived tumour samples

A collection of 100-year old tumour samples held at Great Ormond Street Hospital (GOSH) has helped pinpoint the genetic mutations that cause some of the rarest childhood cancers.

NIHR Great Ormond Street BRC-theme lead Professor Neil Sebire worked with colleagues at the Wellcome Trust Sanger Institute to sequence DNA from tumour samples that had been preserved in blocks of paraffin wax since the 1920s. The team then cross-referenced the samples with archived patient case books which contain information about the patient’s symptoms, condition and diagnosis. Together this information enabled researchers to identify several cancer causing mutations. In one case of the blood vessel cancer (cellular capillary haemangioma) researchers found a mutation in the ASXL1 gene which had not previously been seen in solid tumours.

This proof of principle study shows that it is possible to obtain genetic information from preserved tissue. It also demonstrates the potential of this approach in understanding the genetic basis of rare childhood cancers where the very low incidences mean contemporary tissue samples are scarce

The research was published in a letter to Lancet Oncology  and featured on Radio 4's Inside Science, The Guardian and Nature News.

New Director Designate announced for NIHR GOSH Biomedical Research Centre

Professor Paul Gissen has been announced as the Director Designate of the NIHR GOSH Biomedical Research Centre.

Study linking data from 85% of children in England compares rare cardiac risks post-COVID vs vaccination

A major study which analysed anonymised health records from over 14 million children in England has shown that rare heart and inflammatory issues were more likely - and lasted longer - after COVID-19 infection than after vaccination.

Celebrating research that transforms lives

The 2025 NIHR GOSH BRC Showcase recently celebrated some incredible progress made in paediatric research.

Landmark gene therapy study shows safety for children

Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment.